Little is known about the mechanisms that predispose KS patients to cSCC, although studies in mice have defined a tumor suppressor role for Kindlin-1 in the skin involving control of TGF-β-mediated growth-suppressing signals in cutaneous epithelial stem cells [16]. The gene discussed is FERMT1; the disease is Kindler syndrome.